Circulating SHIP2 mRNA as a novel biomarker in the diagnosis and prognosis of gastric cancer.

CONCLUSIONS: The present study indicated that decreased plasma SHIP2 mRNA level might be a novel diagnostic and prognostic biomarker for GC patients. This conclusion should be further assessed in randomized clinical trials. PMID: 29228424 [PubMed - in process]
Source: European Review for Medical and Pharmacological Sciences - Category: Drugs & Pharmacology Tags: Eur Rev Med Pharmacol Sci Source Type: research